Neurontin Lawsuit

A whistleblower lawsuit alleges that the drug company Parke-Davis devised an illegal strategy to market its anti-epilepsy drug Neurontin for unapproved uses. The suit claims the company gave lavish financial rewards to doctors to create a blockbuster drug. NPR's Snigdha Prakash reports.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

Support comes from: